Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
24,46 USD | -0,12% | +2,73% | -17,14% |
Omzet 2024 * | 316 mln. 296 mln. | Omzet 2025 * | 418 mln. 391 mln. | Marktkapitalisatie | 1,15 mld. 1,08 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -58 mln. -54,25 mln. | Nettowinst (verlies) 2025 * | 18 mln. 16,83 mln. | EV/omzet 2024 * | 2,76 x |
Nettoliquiditeiten 2024 * | 280 mln. 262 mln. | Nettoliquiditeiten 2025 * | 360 mln. 336 mln. | EV/omzet 2025 * | 1,9 x |
K/w-verhouding 2024 * |
-21,6
x | K/w-verhouding 2025 * |
66,6
x | Werknemers | 264 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,88% |
Recentste transcriptie over Mirum Pharmaceuticals, Inc.
1 dag | -0,12% | ||
1 week | +2,73% | ||
Lopende maand | -2,63% | ||
1 maand | -1,85% | ||
3 maanden | -6,53% | ||
6 maanden | -11,18% | ||
Lopend jaar | -17,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 45 | 07-05-18 | |
Michael Grey
FOU | Founder | 71 | 07-05-18 |
Peter Radovich
PSD | President | 46 | 28-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 05-04-23 |
Michael Grey
FOU | Founder | 71 | 07-05-18 |
Patrick Heron
BRD | Director/Board Member | 53 | 07-11-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.04% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 24,46 | -0,12% | 268 335 |
25-04-24 | 24,49 | +1,96% | 817 338 |
24-04-24 | 24,02 | -1,64% | 317 121 |
23-04-24 | 24,42 | +1,03% | 423 071 |
22-04-24 | 24,17 | +1,51% | 254 735 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,14% | 1,15 mld. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |